299 related articles for article (PubMed ID: 27095050)
41. Oral cavity and oropharynx squamous cell carcinoma with metastasis to the parotid lymph nodes.
Olsen SM; Moore EJ; Koch CA; Kasperbauer JL; Olsen KD
Oral Oncol; 2011 Feb; 47(2):142-4. PubMed ID: 21183397
[TBL] [Abstract][Full Text] [Related]
42. Parotideal lymph node metastasis in squamous cell carcinoma of the skin.
Teymoortash A; Dünne AA; Werner JA
Eur J Dermatol; 2002; 12(4):376-80. PubMed ID: 12095888
[TBL] [Abstract][Full Text] [Related]
43. D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: a marker of metastatic risk.
Toll A; Gimeno-Beltrán J; Ferrandiz-Pulido C; Masferrer E; Yébenes M; Jucglà A; Abal L; Martí RM; Sanmartín O; Baró T; Casado B; Gandarillas A; Barranco C; Costa I; Mojal S; García-Patos V; Pujol RM
J Am Acad Dermatol; 2012 Dec; 67(6):1310-8. PubMed ID: 22521203
[TBL] [Abstract][Full Text] [Related]
44. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.
Campos MA; Macedo S; Fernandes M; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
J Am Acad Dermatol; 2019 Mar; 80(3):660-669.e6. PubMed ID: 30165166
[TBL] [Abstract][Full Text] [Related]
45. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.
Thompson AK; Kelley BF; Prokop LJ; Murad MH; Baum CL
JAMA Dermatol; 2016 Apr; 152(4):419-28. PubMed ID: 26762219
[TBL] [Abstract][Full Text] [Related]
46. Characterisation of Prognosis and Invasion of Cutaneous Squamous Cell Carcinoma by Podoplanin and E-Cadherin Expression.
Hesse K; Satzger I; Schacht V; Köther B; Hillen U; Klode J; Schaper K; Gutzmer R
Dermatology; 2016; 232(5):558-565. PubMed ID: 27875814
[TBL] [Abstract][Full Text] [Related]
47. Clinical and histological prognostic factors for local recurrence and metastasis of cutaneous squamous cell carcinoma: analysis of a defined population.
Roozeboom MH; Lohman BG; Westers-Attema A; Nelemans PJ; Botterweck AA; van Marion AM; Kelleners-Smeets NW
Acta Derm Venereol; 2013 Jul; 93(4):417-21. PubMed ID: 23138613
[TBL] [Abstract][Full Text] [Related]
48. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
[TBL] [Abstract][Full Text] [Related]
49. The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma.
Xu R; Cai MY; Luo RZ; Tian X; Han JD; Chen MK
JAMA Dermatol; 2016 Mar; 152(3):305-11. PubMed ID: 26560495
[TBL] [Abstract][Full Text] [Related]
50. Parotid area lymph node metastases from cutaneous squamous cell carcinoma: implications for diagnosis, treatment, and prognosis.
Hong TS; Kriesel KJ; Hartig GK; Harari PM
Head Neck; 2005 Oct; 27(10):851-6. PubMed ID: 16114004
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous squamous cell carcinoma metastatic to the parotid gland in a transplant patient.
Christiansen TN; Freije JE; Neuburg M; Roza A
Clin Transplant; 1996 Dec; 10(6 Pt 1):561-3. PubMed ID: 8996779
[TBL] [Abstract][Full Text] [Related]
52. Multiple synchronous cutaneous squamous cell carcinomas of the head and neck: a case report.
Ahn JH; Abu-Serriah M; Ameerally P
J Oral Maxillofac Surg; 2011 Oct; 69(10):e317-23. PubMed ID: 21813221
[TBL] [Abstract][Full Text] [Related]
53. Tumor Budding Is an Objective High-risk Factor Associated With Metastasis and Poor Clinical Prognosis in Cutaneous Squamous Cell Carcinoma Sized <4 cm.
Fujimoto M; Yamamoto Y; Takai T; Fujimoto N; Ogawa K; Yoshikawa T; Matsuzaki I; Takahashi Y; Iwahashi Y; Warigaya K; Kojima F; Jinnin M; Murata SI
Am J Surg Pathol; 2019 Jul; 43(7):975-983. PubMed ID: 31094931
[TBL] [Abstract][Full Text] [Related]
54. Serum matrix metalloproteinase-13 as a diagnostic biomarker for cutaneous squamous cell carcinoma.
Wang H; Li H; Yan Q; Gao S; Gao J; Wang Z; Sun Y
BMC Cancer; 2021 Jul; 21(1):816. PubMed ID: 34266392
[TBL] [Abstract][Full Text] [Related]
55. Active nuclear IKK correlates with metastatic risk in cutaneous squamous cell carcinoma.
Toll A; Margalef P; Masferrer E; Ferrándiz-Pulido C; Gimeno J; Pujol RM; Bigas A; Espinosa L
Arch Dermatol Res; 2015 Oct; 307(8):721-9. PubMed ID: 26094020
[TBL] [Abstract][Full Text] [Related]
56. Significance of clinical stage, extent of surgery and outcome in cutaneous squamous cell carcinoma of the head and neck.
Košec A; Svetina L; Lukšić I
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):82-8. PubMed ID: 23137734
[TBL] [Abstract][Full Text] [Related]
57. [Significance of parotid metastases of squamous cell carcinoma of scalp].
Teymoortash A; Schultz ES; Werner JA
Hautarzt; 2007 Apr; 58(4):323-7. PubMed ID: 17237930
[TBL] [Abstract][Full Text] [Related]
58. Parotid gland metastasis in Merkel cell carcinoma of the head and neck: A series of 14 cases.
Day KE; Carroll WR; Rosenthal EL
Ear Nose Throat J; 2016 Sep; 95(9):398-404. PubMed ID: 27657318
[TBL] [Abstract][Full Text] [Related]
59. Predictors of Recurrence and Progression in Poorly Differentiated Cutaneous Squamous Cell Carcinomas: Insights from a Real-Life Experience.
Roccuzzo G; Orlando G; Rumore MR; Morrone A; Fruttero E; Caliendo V; Picciotto F; Sciarrillo A; Quaglino P; Cassoni P; Ribero S; Senetta R
Dermatology; 2024; 240(2):329-336. PubMed ID: 38008073
[TBL] [Abstract][Full Text] [Related]
60. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
